Common Cold Revisited
Journal Title: The Indian Practitioner - Year 2015, Vol 68, Issue 9
Abstract
The common cold, or upper respiratory tract infection, is one of the leading reasons for physician visits. Its impact on society and health care is large. Rhinoviruses are the most frequent cause. The virus is spread by hand contact with secretions from an infected person (direct or indirect) or aerosol of the secretions and virus. There is no proven treatment for the common cold. Therefore, the common cold is treated symptomatically. Prophylactic probiotics, zinc sulphate, nasal saline irrigation, and the herbal preparations containing Echinacea angustifolia reduce the incidence of cold. Nonsteroidal antiinflammatory drugs and some herbal preparations, including Echinacea purpurea, improve symptoms. Hand hygiene reduces the spread of viruses that cause cold illnesses.
Authors and Affiliations
Arun Tyagi, M Waran, S Patel
Keywords
Related Articles
- EP ID EP585518
- DOI -
- Views 57
- Downloads 0
An Interesting Case of Duodenal Perforation with Penetrating Hepatic Injury by an Ingested 17 cm Long Neem Stick
Foreign bodies, ingested either accidentally or intentionally usually pass through gastrointestinal tract uneventfully. However few cases presents with complications such as perforation, obstruction or haemorrhage or fis...
Frequency And Distribution of ABO And Rh (Factor) Blood Groups Among Medical Students of Central India, Rewa, Madhya Pradesh
This study was conducted in the department of Physiology at S.S. Medical College, Rewa, MP with the aim to determine the frequency and distribution of “A, B, AB, O and Rh” blood groups among medical students and link the...
Pulmonary involvement in Dengue presenting as consolidation - A Case Report
Dengue is a major health illness affecting tropical and subtropical areas especially in urban and peri-urban areas. It is an arboviral disease transmitted by the mosquito Aedes aegypti and is caused by four antigenically...
Teneligliptin – The Newest DPP4 Inhibitor
Teneligliptin is the newest DPP4 inhibitor approved by the regulatory authority for the treatment of Diabetes mellitus. Teneligliptin scores over other ‘gliptins’ in being more economical and with better efficacy to cont...
Cardiac Sarcoidosis presenting as aborted sudden death
A 42 year old lady with a diagnosis of hyperreactive airway disease since 4 years, treated with bronchodilators presented with monomorphic ventricular tachycardia with syncope requiring direct current (DC) cardioversion....